| Immobilization induced osteopenia is strain specific in mice A Lodberg, JB Vegger, MV Jensen, CM Larsen, JS Thomsen, A Brüel Bone Reports 2, 59-67, 2015 | 37 | 2015 |
| Principles of the activin receptor signaling pathway and its inhibition A Lodberg Cytokine & Growth Factor Reviews 60, 1-17, 2021 | 26 | 2021 |
| A follistatin‐based molecule increases muscle and bone mass without affecting the red blood cell count in mice A Lodberg, BCJ van der Eerden, B Boers‐Sijmons, JS Thomsen, A Brüel, ... The FASEB Journal 33 (5), 6001-6010, 2019 | 24 | 2019 |
| Sex-specific effect of high-fat diet on glycerol metabolism in murine adipose tissue and liver FM Iena, JB Jul, JB Vegger, A Lodberg, JS Thomsen, A Brüel, J Lebeck Frontiers in endocrinology 11, 577650, 2020 | 18 | 2020 |
| A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia A Lodberg, M Eijken, BCJ van der Eerden, MW Okkels, JS Thomsen, ... Bone 110, 326-334, 2018 | 16 | 2018 |
| Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A MB Brent, A Lodberg, JS Thomsen, A Brüel MethodsX 7, 101079, 2020 | 11 | 2020 |
| Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice MB Brent, A Lodberg, FD Bromer, BCJ van der Eerden, M Eijken, A Brüel, ... Bone 142, 115692, 2021 | 8 | 2021 |
| Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma D Meier, A Lodberg, A Gvozdenovic, G Pellegrini, O Neklyudova, W Born, ... Cancer medicine 10 (1), 286-296, 2021 | 4 | 2021 |
| Highly Responsive Bioassay for Quantification of Glucocorticoids MF Poulsen, M Overgaard, CB Folsted Andersen, A Lodberg Analytical Chemistry, 2024 | | 2024 |
| P64 An activin type II receptor ligand trap prevented loss of cortical bone strength and cancellous bone mass in a mouse model of severe disuse osteopenia MF Poulsen, F Fisher, J Lachey, J Seehra, C Andersen, M Eijken, ... Neuromuscular Disorders 33, S74-S75, 2023 | | 2023 |
| P173 A highly responsive bioassay for quantification of glucocorticoids M Poulsen, M Overgaard, C Andersen, A Lodberg Neuromuscular Disorders 33, S108, 2023 | | 2023 |
| Additive effect of Act-RIIA-mFc and PTH in the prevention of disuse-induced bone loss MB Brent, F Duch, A Lodberg, U Simonsen, BCJ van der Eerden, ... Bone Reports 13, 100322, 2020 | | 2020 |
| Activin decoy receptor (IIA) ameliorates immobilisation induced loss of bone and muscle mass in mice A Lodberg, JS Thomsen, A Bruel Bone Abstracts 3, 2014 | | 2014 |
